TherapeuticsMD, Inc. Basic Shares Outstanding (Weighted Average)
TherapeuticsMD, Inc. (TXMD) reported Basic Shares Outstanding (Weighted Average) of 11.57 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- TherapeuticsMD, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 11.57M shares, a 0.00% change year-over-year.
- TherapeuticsMD, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.57K shares, a 0.19% increase year-over-year.
- TherapeuticsMD, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.57M shares, a 0.37% increase year-over-year.
- TherapeuticsMD, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 11.57M shares, a 0.36% increase year-over-year.
- TherapeuticsMD, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 11.57M shares, a 0.32% increase from fiscal 2024.
- TherapeuticsMD, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 11.53M shares, a 110349.19% increase from fiscal 2023.
- TherapeuticsMD, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 10.44K shares, a 99.88% decline from fiscal 2022.
- TherapeuticsMD, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 9.03M shares, a 13.42% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 11.57M shares 10-Q · filed 2026-08-11 | 11.57M shares 10-Q · filed 2026-08-11 | 7.72M shares derived: average of 3 quarters · filed 2026-08-11 | 8.68M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 11.57K shares 10-Q · filed 2026-05-12 | 5.79M shares derived: average of 2 quarters · filed 2026-05-12 | 7.72M shares derived: average of 3 quarters · filed 2026-05-12 | 8.68M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 11.57M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-01 | 11.57M shares derived: average of 2 quarters · filed 2026-04-01 | 11.57M shares derived: average of 3 quarters · filed 2026-08-11 | 11.57M shares 10-K/A · filed 2026-04-01 | ||||
| 2025-09-30 | 11.57M shares 10-Q · filed 2025-11-12 | 11.57M shares derived: average of 2 quarters · filed 2026-08-11 | 11.57M shares 10-Q · filed 2025-11-12 | 8.67M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 11.57M shares 10-Q · filed 2026-08-11 | 11.56M shares 10-Q · filed 2026-08-11 | 7.71M shares derived: average of 3 quarters · filed 2026-08-11 | 8.66M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 11.55K shares 10-Q · filed 2026-05-12 | 11.55M shares 10-Q · filed 2025-05-13 | 5.77M shares derived: average of 2 quarters · filed 2026-05-12 | 7.69M shares derived: average of 3 quarters · filed 2026-05-12 | 8.65M shares derived: average of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | 11.53M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-01 | 11.53M shares derived: average of 2 quarters · filed 2026-04-01 | 11.53M shares derived: average of 3 quarters · filed 2026-04-01 | 11.53M shares 10-K/A · filed 2026-04-01 | 11.53K shares 10-K · filed 2025-03-27 | |||
| 2024-09-30 | 11.53M shares 10-Q · filed 2025-11-12 | 11.53M shares derived: average of 2 quarters · filed 2025-11-12 | 11.53M shares 10-Q · filed 2025-11-12 | 978.69K shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 11.53M shares 10-Q · filed 2025-08-12 | 11.53M shares 10-Q · filed 2025-08-12 | -2.54M shares derived: average of 3 quarters · filed 2025-08-12 | 770.94K shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 11.53M shares 10-Q · filed 2025-05-13 | -9.57M shares derived: average of 2 quarters · filed 2025-05-13 | -2.82M shares derived: average of 3 quarters · filed 2025-05-13 | 442.69K shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -30.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -9.99M shares derived: average of 2 quarters · filed 2025-03-27 | -3.25M shares derived: average of 3 quarters · filed 2025-03-27 | 10.44K shares 10-K · filed 2025-03-27 | 10.44M shares 10-K · filed 2024-03-29 | |||
| 2023-09-30 | 10.70M shares 10-Q · filed 2023-11-14 | 10.46M shares derived: average of 2 quarters · filed 2024-08-12 | 10.24M shares 10-Q · filed 2023-11-14 | 10.04M shares derived: average of 4 quarters · filed 2024-08-12 | ||||
| 2023-06-30 | 10.22M shares 10-Q · filed 2024-08-12 | 9.99M shares 10-Q · filed 2024-08-12 | 9.82M shares derived: average of 3 quarters · filed 2024-08-12 | 9.68M shares derived: average of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | 9.75M shares 10-Q · filed 2023-05-15 | 9.62M shares derived: average of 2 quarters · filed 2024-03-29 | 9.50M shares derived: average of 3 quarters · filed 2024-03-29 | 9.31M shares derived: average of 4 quarters · filed 2024-03-29 | ||||
| 2022-12-31 | 9.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 9.37M shares derived: average of 2 quarters · filed 2024-03-29 | 9.16M shares derived: average of 3 quarters · filed 2024-03-29 | 9.03M shares 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | 9.26M shares 10-Q · filed 2023-11-14 | 9.01M shares derived: average of 2 quarters · filed 2023-11-14 | 8.88M shares 10-Q · filed 2023-11-14 | 8.79M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 8.75M shares 10-Q · filed 2023-08-14 | 8.68M shares 10-Q · filed 2023-08-14 | 8.64M shares derived: average of 3 quarters · filed 2023-08-14 | 8.59M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 8.61M shares 10-Q · filed 2023-05-15 | 8.58M shares derived: average of 2 quarters · filed 2023-05-15 | 8.54M shares derived: average of 3 quarters · filed 2023-05-15 | 8.37M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 8.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-07 | 8.50M shares derived: average of 2 quarters · filed 2023-04-07 | 8.29M shares derived: average of 3 quarters · filed 2023-04-07 | 7.96M shares 10-K · filed 2023-04-07 | 397.99M shares 10-K · filed 2022-03-23 | |||
| 2021-09-30 | 8.44M shares 10-Q · filed 2022-11-14 | 422.22M shares 10-Q · filed 2021-11-12 | 8.16M shares derived: average of 2 quarters · filed 2022-11-14 | 7.76M shares 10-Q · filed 2022-11-14 | 388.11M shares 10-Q · filed 2021-11-12 | 77.49M shares derived: average of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | 7.88M shares 10-Q · filed 2022-08-15 | 394.07M shares 10-Q · filed 2021-08-04 | 7.42M shares 10-Q · filed 2022-08-15 | 370.78M shares 10-Q · filed 2021-08-04 | 100.50M shares derived: average of 3 quarters · filed 2022-08-15 | 143.52M shares derived: average of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | 6.95M shares 10-Q · filed 2022-05-16 | 347.22M shares 10-Q · filed 2021-05-06 | 146.82M shares derived: average of 2 quarters · filed 2022-05-16 | 188.73M shares derived: average of 3 quarters · filed 2022-05-16 | 209.52M shares derived: average of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | 286.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 279.63M shares derived: average of 2 quarters · filed 2022-03-23 | 277.04M shares derived: average of 3 quarters · filed 2022-03-23 | 275.65M shares 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | 272.56M shares 10-Q · filed 2021-11-12 | 272.22M shares derived: average of 2 quarters · filed 2021-11-12 | 271.97M shares 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | 271.88M shares 10-Q · filed 2021-08-04 | 271.67M shares 10-Q · filed 2021-08-04 | ||||||
| 2020-03-31 | 271.46M shares 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | 246.35M shares 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |